The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Recombinant Erythropoietin Market Research Report 2024
Synopsis
The global Recombinant Erythropoietin market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Recombinant Erythropoietin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Recombinant Erythropoietin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Recombinant Erythropoietin in Chronic Kidney Disease is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Recombinant Erythropoietin include Amgen, Johnson & Johnson, Kyowa Hakko Kirin, Roche, 3SBio Group, Celltrion, Inc, Teva Pharmaceutical Industries Ltd, F. Hoffmann-La Roche Ltd and LG Life Sciences Ltd, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Recombinant Erythropoietin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Recombinant Erythropoietin.
Report Scope
The Recombinant Erythropoietin market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Recombinant Erythropoietin market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Recombinant Erythropoietin companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Amgen
Johnson & Johnson
Kyowa Hakko Kirin
Roche
3SBio Group
Celltrion, Inc
Teva Pharmaceutical Industries Ltd
F. Hoffmann-La Roche Ltd
LG Life Sciences Ltd
Biocon Limited
Intas Pharmaceuticals Ltd
Sun Pharmaceutical Industries Ltd
Dr. Reddy's Laboratories Ltd
Segment by Type
rhEPO
Erythropoiesis-Stimulating Agents (ESA)
Segment by Application
Chronic Kidney Disease
Cancer Related Anemia
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Recombinant Erythropoietin companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global Recombinant Erythropoietin market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Recombinant Erythropoietin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Recombinant Erythropoietin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Recombinant Erythropoietin in Chronic Kidney Disease is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Recombinant Erythropoietin include Amgen, Johnson & Johnson, Kyowa Hakko Kirin, Roche, 3SBio Group, Celltrion, Inc, Teva Pharmaceutical Industries Ltd, F. Hoffmann-La Roche Ltd and LG Life Sciences Ltd, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Recombinant Erythropoietin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Recombinant Erythropoietin.
Report Scope
The Recombinant Erythropoietin market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Recombinant Erythropoietin market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Recombinant Erythropoietin companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Amgen
Johnson & Johnson
Kyowa Hakko Kirin
Roche
3SBio Group
Celltrion, Inc
Teva Pharmaceutical Industries Ltd
F. Hoffmann-La Roche Ltd
LG Life Sciences Ltd
Biocon Limited
Intas Pharmaceuticals Ltd
Sun Pharmaceutical Industries Ltd
Dr. Reddy's Laboratories Ltd
Segment by Type
rhEPO
Erythropoiesis-Stimulating Agents (ESA)
Segment by Application
Chronic Kidney Disease
Cancer Related Anemia
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Recombinant Erythropoietin companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Recombinant Erythropoietin Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 rhEPO
1.2.3 Erythropoiesis-Stimulating Agents (ESA)
1.3 Market by Application
1.3.1 Global Recombinant Erythropoietin Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Chronic Kidney Disease
1.3.3 Cancer Related Anemia
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Recombinant Erythropoietin Market Perspective (2019-2030)
2.2 Recombinant Erythropoietin Growth Trends by Region
2.2.1 Global Recombinant Erythropoietin Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Recombinant Erythropoietin Historic Market Size by Region (2019-2024)
2.2.3 Recombinant Erythropoietin Forecasted Market Size by Region (2025-2030)
2.3 Recombinant Erythropoietin Market Dynamics
2.3.1 Recombinant Erythropoietin Industry Trends
2.3.2 Recombinant Erythropoietin Market Drivers
2.3.3 Recombinant Erythropoietin Market Challenges
2.3.4 Recombinant Erythropoietin Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Recombinant Erythropoietin Players by Revenue
3.1.1 Global Top Recombinant Erythropoietin Players by Revenue (2019-2024)
3.1.2 Global Recombinant Erythropoietin Revenue Market Share by Players (2019-2024)
3.2 Global Recombinant Erythropoietin Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Recombinant Erythropoietin Revenue
3.4 Global Recombinant Erythropoietin Market Concentration Ratio
3.4.1 Global Recombinant Erythropoietin Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Recombinant Erythropoietin Revenue in 2023
3.5 Recombinant Erythropoietin Key Players Head office and Area Served
3.6 Key Players Recombinant Erythropoietin Product Solution and Service
3.7 Date of Enter into Recombinant Erythropoietin Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Recombinant Erythropoietin Breakdown Data by Type
4.1 Global Recombinant Erythropoietin Historic Market Size by Type (2019-2024)
4.2 Global Recombinant Erythropoietin Forecasted Market Size by Type (2025-2030)
5 Recombinant Erythropoietin Breakdown Data by Application
5.1 Global Recombinant Erythropoietin Historic Market Size by Application (2019-2024)
5.2 Global Recombinant Erythropoietin Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Recombinant Erythropoietin Market Size (2019-2030)
6.2 North America Recombinant Erythropoietin Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Recombinant Erythropoietin Market Size by Country (2019-2024)
6.4 North America Recombinant Erythropoietin Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Recombinant Erythropoietin Market Size (2019-2030)
7.2 Europe Recombinant Erythropoietin Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Recombinant Erythropoietin Market Size by Country (2019-2024)
7.4 Europe Recombinant Erythropoietin Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Recombinant Erythropoietin Market Size (2019-2030)
8.2 Asia-Pacific Recombinant Erythropoietin Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Recombinant Erythropoietin Market Size by Region (2019-2024)
8.4 Asia-Pacific Recombinant Erythropoietin Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Recombinant Erythropoietin Market Size (2019-2030)
9.2 Latin America Recombinant Erythropoietin Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Recombinant Erythropoietin Market Size by Country (2019-2024)
9.4 Latin America Recombinant Erythropoietin Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Recombinant Erythropoietin Market Size (2019-2030)
10.2 Middle East & Africa Recombinant Erythropoietin Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Recombinant Erythropoietin Market Size by Country (2019-2024)
10.4 Middle East & Africa Recombinant Erythropoietin Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Amgen
11.1.1 Amgen Company Detail
11.1.2 Amgen Business Overview
11.1.3 Amgen Recombinant Erythropoietin Introduction
11.1.4 Amgen Revenue in Recombinant Erythropoietin Business (2019-2024)
11.1.5 Amgen Recent Development
11.2 Johnson & Johnson
11.2.1 Johnson & Johnson Company Detail
11.2.2 Johnson & Johnson Business Overview
11.2.3 Johnson & Johnson Recombinant Erythropoietin Introduction
11.2.4 Johnson & Johnson Revenue in Recombinant Erythropoietin Business (2019-2024)
11.2.5 Johnson & Johnson Recent Development
11.3 Kyowa Hakko Kirin
11.3.1 Kyowa Hakko Kirin Company Detail
11.3.2 Kyowa Hakko Kirin Business Overview
11.3.3 Kyowa Hakko Kirin Recombinant Erythropoietin Introduction
11.3.4 Kyowa Hakko Kirin Revenue in Recombinant Erythropoietin Business (2019-2024)
11.3.5 Kyowa Hakko Kirin Recent Development
11.4 Roche
11.4.1 Roche Company Detail
11.4.2 Roche Business Overview
11.4.3 Roche Recombinant Erythropoietin Introduction
11.4.4 Roche Revenue in Recombinant Erythropoietin Business (2019-2024)
11.4.5 Roche Recent Development
11.5 3SBio Group
11.5.1 3SBio Group Company Detail
11.5.2 3SBio Group Business Overview
11.5.3 3SBio Group Recombinant Erythropoietin Introduction
11.5.4 3SBio Group Revenue in Recombinant Erythropoietin Business (2019-2024)
11.5.5 3SBio Group Recent Development
11.6 Celltrion, Inc
11.6.1 Celltrion, Inc Company Detail
11.6.2 Celltrion, Inc Business Overview
11.6.3 Celltrion, Inc Recombinant Erythropoietin Introduction
11.6.4 Celltrion, Inc Revenue in Recombinant Erythropoietin Business (2019-2024)
11.6.5 Celltrion, Inc Recent Development
11.7 Teva Pharmaceutical Industries Ltd
11.7.1 Teva Pharmaceutical Industries Ltd Company Detail
11.7.2 Teva Pharmaceutical Industries Ltd Business Overview
11.7.3 Teva Pharmaceutical Industries Ltd Recombinant Erythropoietin Introduction
11.7.4 Teva Pharmaceutical Industries Ltd Revenue in Recombinant Erythropoietin Business (2019-2024)
11.7.5 Teva Pharmaceutical Industries Ltd Recent Development
11.8 F. Hoffmann-La Roche Ltd
11.8.1 F. Hoffmann-La Roche Ltd Company Detail
11.8.2 F. Hoffmann-La Roche Ltd Business Overview
11.8.3 F. Hoffmann-La Roche Ltd Recombinant Erythropoietin Introduction
11.8.4 F. Hoffmann-La Roche Ltd Revenue in Recombinant Erythropoietin Business (2019-2024)
11.8.5 F. Hoffmann-La Roche Ltd Recent Development
11.9 LG Life Sciences Ltd
11.9.1 LG Life Sciences Ltd Company Detail
11.9.2 LG Life Sciences Ltd Business Overview
11.9.3 LG Life Sciences Ltd Recombinant Erythropoietin Introduction
11.9.4 LG Life Sciences Ltd Revenue in Recombinant Erythropoietin Business (2019-2024)
11.9.5 LG Life Sciences Ltd Recent Development
11.10 Biocon Limited
11.10.1 Biocon Limited Company Detail
11.10.2 Biocon Limited Business Overview
11.10.3 Biocon Limited Recombinant Erythropoietin Introduction
11.10.4 Biocon Limited Revenue in Recombinant Erythropoietin Business (2019-2024)
11.10.5 Biocon Limited Recent Development
11.11 Intas Pharmaceuticals Ltd
11.11.1 Intas Pharmaceuticals Ltd Company Detail
11.11.2 Intas Pharmaceuticals Ltd Business Overview
11.11.3 Intas Pharmaceuticals Ltd Recombinant Erythropoietin Introduction
11.11.4 Intas Pharmaceuticals Ltd Revenue in Recombinant Erythropoietin Business (2019-2024)
11.11.5 Intas Pharmaceuticals Ltd Recent Development
11.12 Sun Pharmaceutical Industries Ltd
11.12.1 Sun Pharmaceutical Industries Ltd Company Detail
11.12.2 Sun Pharmaceutical Industries Ltd Business Overview
11.12.3 Sun Pharmaceutical Industries Ltd Recombinant Erythropoietin Introduction
11.12.4 Sun Pharmaceutical Industries Ltd Revenue in Recombinant Erythropoietin Business (2019-2024)
11.12.5 Sun Pharmaceutical Industries Ltd Recent Development
11.13 Dr. Reddy's Laboratories Ltd
11.13.1 Dr. Reddy's Laboratories Ltd Company Detail
11.13.2 Dr. Reddy's Laboratories Ltd Business Overview
11.13.3 Dr. Reddy's Laboratories Ltd Recombinant Erythropoietin Introduction
11.13.4 Dr. Reddy's Laboratories Ltd Revenue in Recombinant Erythropoietin Business (2019-2024)
11.13.5 Dr. Reddy's Laboratories Ltd Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Recombinant Erythropoietin Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of rhEPO
Table 3. Key Players of Erythropoiesis-Stimulating Agents (ESA)
Table 4. Global Recombinant Erythropoietin Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global Recombinant Erythropoietin Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Recombinant Erythropoietin Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global Recombinant Erythropoietin Market Share by Region (2019-2024)
Table 8. Global Recombinant Erythropoietin Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global Recombinant Erythropoietin Market Share by Region (2025-2030)
Table 10. Recombinant Erythropoietin Market Trends
Table 11. Recombinant Erythropoietin Market Drivers
Table 12. Recombinant Erythropoietin Market Challenges
Table 13. Recombinant Erythropoietin Market Restraints
Table 14. Global Recombinant Erythropoietin Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global Recombinant Erythropoietin Market Share by Players (2019-2024)
Table 16. Global Top Recombinant Erythropoietin Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Recombinant Erythropoietin as of 2023)
Table 17. Ranking of Global Top Recombinant Erythropoietin Companies by Revenue (US$ Million) in 2023
Table 18. Global 5 Largest Players Market Share by Recombinant Erythropoietin Revenue (CR5 and HHI) & (2019-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Recombinant Erythropoietin Product Solution and Service
Table 21. Date of Enter into Recombinant Erythropoietin Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Recombinant Erythropoietin Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global Recombinant Erythropoietin Revenue Market Share by Type (2019-2024)
Table 25. Global Recombinant Erythropoietin Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global Recombinant Erythropoietin Revenue Market Share by Type (2025-2030)
Table 27. Global Recombinant Erythropoietin Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global Recombinant Erythropoietin Revenue Market Share by Application (2019-2024)
Table 29. Global Recombinant Erythropoietin Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global Recombinant Erythropoietin Revenue Market Share by Application (2025-2030)
Table 31. North America Recombinant Erythropoietin Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 32. North America Recombinant Erythropoietin Market Size by Country (2019-2024) & (US$ Million)
Table 33. North America Recombinant Erythropoietin Market Size by Country (2025-2030) & (US$ Million)
Table 34. Europe Recombinant Erythropoietin Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. Europe Recombinant Erythropoietin Market Size by Country (2019-2024) & (US$ Million)
Table 36. Europe Recombinant Erythropoietin Market Size by Country (2025-2030) & (US$ Million)
Table 37. Asia-Pacific Recombinant Erythropoietin Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 38. Asia-Pacific Recombinant Erythropoietin Market Size by Region (2019-2024) & (US$ Million)
Table 39. Asia-Pacific Recombinant Erythropoietin Market Size by Region (2025-2030) & (US$ Million)
Table 40. Latin America Recombinant Erythropoietin Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Latin America Recombinant Erythropoietin Market Size by Country (2019-2024) & (US$ Million)
Table 42. Latin America Recombinant Erythropoietin Market Size by Country (2025-2030) & (US$ Million)
Table 43. Middle East & Africa Recombinant Erythropoietin Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Middle East & Africa Recombinant Erythropoietin Market Size by Country (2019-2024) & (US$ Million)
Table 45. Middle East & Africa Recombinant Erythropoietin Market Size by Country (2025-2030) & (US$ Million)
Table 46. Amgen Company Detail
Table 47. Amgen Business Overview
Table 48. Amgen Recombinant Erythropoietin Product
Table 49. Amgen Revenue in Recombinant Erythropoietin Business (2019-2024) & (US$ Million)
Table 50. Amgen Recent Development
Table 51. Johnson & Johnson Company Detail
Table 52. Johnson & Johnson Business Overview
Table 53. Johnson & Johnson Recombinant Erythropoietin Product
Table 54. Johnson & Johnson Revenue in Recombinant Erythropoietin Business (2019-2024) & (US$ Million)
Table 55. Johnson & Johnson Recent Development
Table 56. Kyowa Hakko Kirin Company Detail
Table 57. Kyowa Hakko Kirin Business Overview
Table 58. Kyowa Hakko Kirin Recombinant Erythropoietin Product
Table 59. Kyowa Hakko Kirin Revenue in Recombinant Erythropoietin Business (2019-2024) & (US$ Million)
Table 60. Kyowa Hakko Kirin Recent Development
Table 61. Roche Company Detail
Table 62. Roche Business Overview
Table 63. Roche Recombinant Erythropoietin Product
Table 64. Roche Revenue in Recombinant Erythropoietin Business (2019-2024) & (US$ Million)
Table 65. Roche Recent Development
Table 66. 3SBio Group Company Detail
Table 67. 3SBio Group Business Overview
Table 68. 3SBio Group Recombinant Erythropoietin Product
Table 69. 3SBio Group Revenue in Recombinant Erythropoietin Business (2019-2024) & (US$ Million)
Table 70. 3SBio Group Recent Development
Table 71. Celltrion, Inc Company Detail
Table 72. Celltrion, Inc Business Overview
Table 73. Celltrion, Inc Recombinant Erythropoietin Product
Table 74. Celltrion, Inc Revenue in Recombinant Erythropoietin Business (2019-2024) & (US$ Million)
Table 75. Celltrion, Inc Recent Development
Table 76. Teva Pharmaceutical Industries Ltd Company Detail
Table 77. Teva Pharmaceutical Industries Ltd Business Overview
Table 78. Teva Pharmaceutical Industries Ltd Recombinant Erythropoietin Product
Table 79. Teva Pharmaceutical Industries Ltd Revenue in Recombinant Erythropoietin Business (2019-2024) & (US$ Million)
Table 80. Teva Pharmaceutical Industries Ltd Recent Development
Table 81. F. Hoffmann-La Roche Ltd Company Detail
Table 82. F. Hoffmann-La Roche Ltd Business Overview
Table 83. F. Hoffmann-La Roche Ltd Recombinant Erythropoietin Product
Table 84. F. Hoffmann-La Roche Ltd Revenue in Recombinant Erythropoietin Business (2019-2024) & (US$ Million)
Table 85. F. Hoffmann-La Roche Ltd Recent Development
Table 86. LG Life Sciences Ltd Company Detail
Table 87. LG Life Sciences Ltd Business Overview
Table 88. LG Life Sciences Ltd Recombinant Erythropoietin Product
Table 89. LG Life Sciences Ltd Revenue in Recombinant Erythropoietin Business (2019-2024) & (US$ Million)
Table 90. LG Life Sciences Ltd Recent Development
Table 91. Biocon Limited Company Detail
Table 92. Biocon Limited Business Overview
Table 93. Biocon Limited Recombinant Erythropoietin Product
Table 94. Biocon Limited Revenue in Recombinant Erythropoietin Business (2019-2024) & (US$ Million)
Table 95. Biocon Limited Recent Development
Table 96. Intas Pharmaceuticals Ltd Company Detail
Table 97. Intas Pharmaceuticals Ltd Business Overview
Table 98. Intas Pharmaceuticals Ltd Recombinant Erythropoietin Product
Table 99. Intas Pharmaceuticals Ltd Revenue in Recombinant Erythropoietin Business (2019-2024) & (US$ Million)
Table 100. Intas Pharmaceuticals Ltd Recent Development
Table 101. Sun Pharmaceutical Industries Ltd Company Detail
Table 102. Sun Pharmaceutical Industries Ltd Business Overview
Table 103. Sun Pharmaceutical Industries Ltd Recombinant Erythropoietin Product
Table 104. Sun Pharmaceutical Industries Ltd Revenue in Recombinant Erythropoietin Business (2019-2024) & (US$ Million)
Table 105. Sun Pharmaceutical Industries Ltd Recent Development
Table 106. Dr. Reddy's Laboratories Ltd Company Detail
Table 107. Dr. Reddy's Laboratories Ltd Business Overview
Table 108. Dr. Reddy's Laboratories Ltd Recombinant Erythropoietin Product
Table 109. Dr. Reddy's Laboratories Ltd Revenue in Recombinant Erythropoietin Business (2019-2024) & (US$ Million)
Table 110. Dr. Reddy's Laboratories Ltd Recent Development
Table 111. Research Programs/Design for This Report
Table 112. Key Data Information from Secondary Sources
Table 113. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Recombinant Erythropoietin Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Recombinant Erythropoietin Market Share by Type: 2023 VS 2030
Figure 3. rhEPO Features
Figure 4. Erythropoiesis-Stimulating Agents (ESA) Features
Figure 5. Global Recombinant Erythropoietin Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 6. Global Recombinant Erythropoietin Market Share by Application: 2023 VS 2030
Figure 7. Chronic Kidney Disease Case Studies
Figure 8. Cancer Related Anemia Case Studies
Figure 9. Others Case Studies
Figure 10. Recombinant Erythropoietin Report Years Considered
Figure 11. Global Recombinant Erythropoietin Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 12. Global Recombinant Erythropoietin Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Recombinant Erythropoietin Market Share by Region: 2023 VS 2030
Figure 14. Global Recombinant Erythropoietin Market Share by Players in 2023
Figure 15. Global Top Recombinant Erythropoietin Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Recombinant Erythropoietin as of 2023)
Figure 16. The Top 10 and 5 Players Market Share by Recombinant Erythropoietin Revenue in 2023
Figure 17. North America Recombinant Erythropoietin Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 18. North America Recombinant Erythropoietin Market Share by Country (2019-2030)
Figure 19. United States Recombinant Erythropoietin Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. Canada Recombinant Erythropoietin Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Europe Recombinant Erythropoietin Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Recombinant Erythropoietin Market Share by Country (2019-2030)
Figure 23. Germany Recombinant Erythropoietin Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. France Recombinant Erythropoietin Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. U.K. Recombinant Erythropoietin Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Italy Recombinant Erythropoietin Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Russia Recombinant Erythropoietin Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Nordic Countries Recombinant Erythropoietin Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Asia-Pacific Recombinant Erythropoietin Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific Recombinant Erythropoietin Market Share by Region (2019-2030)
Figure 31. China Recombinant Erythropoietin Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Japan Recombinant Erythropoietin Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. South Korea Recombinant Erythropoietin Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Southeast Asia Recombinant Erythropoietin Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. India Recombinant Erythropoietin Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Australia Recombinant Erythropoietin Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Latin America Recombinant Erythropoietin Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America Recombinant Erythropoietin Market Share by Country (2019-2030)
Figure 39. Mexico Recombinant Erythropoietin Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Brazil Recombinant Erythropoietin Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Middle East & Africa Recombinant Erythropoietin Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Recombinant Erythropoietin Market Share by Country (2019-2030)
Figure 43. Turkey Recombinant Erythropoietin Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Saudi Arabia Recombinant Erythropoietin Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Amgen Revenue Growth Rate in Recombinant Erythropoietin Business (2019-2024)
Figure 46. Johnson & Johnson Revenue Growth Rate in Recombinant Erythropoietin Business (2019-2024)
Figure 47. Kyowa Hakko Kirin Revenue Growth Rate in Recombinant Erythropoietin Business (2019-2024)
Figure 48. Roche Revenue Growth Rate in Recombinant Erythropoietin Business (2019-2024)
Figure 49. 3SBio Group Revenue Growth Rate in Recombinant Erythropoietin Business (2019-2024)
Figure 50. Celltrion, Inc Revenue Growth Rate in Recombinant Erythropoietin Business (2019-2024)
Figure 51. Teva Pharmaceutical Industries Ltd Revenue Growth Rate in Recombinant Erythropoietin Business (2019-2024)
Figure 52. F. Hoffmann-La Roche Ltd Revenue Growth Rate in Recombinant Erythropoietin Business (2019-2024)
Figure 53. LG Life Sciences Ltd Revenue Growth Rate in Recombinant Erythropoietin Business (2019-2024)
Figure 54. Biocon Limited Revenue Growth Rate in Recombinant Erythropoietin Business (2019-2024)
Figure 55. Intas Pharmaceuticals Ltd Revenue Growth Rate in Recombinant Erythropoietin Business (2019-2024)
Figure 56. Sun Pharmaceutical Industries Ltd Revenue Growth Rate in Recombinant Erythropoietin Business (2019-2024)
Figure 57. Dr. Reddy's Laboratories Ltd Revenue Growth Rate in Recombinant Erythropoietin Business (2019-2024)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
